Hubei Sanjing Biotechnology, established in 1999, manufactures antibiotic active ingredients and chiral intermediates, distributing to markets across North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa.
留下您的评分和评论